- Home
- PCVX vs FRSH Comparison
PCVX vs FRSH Comparison
Compare PCVX & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- FRSH
- Stock Information
- Founded
- PCVX 2013
- FRSH 2010
- Country
- PCVX United States
- FRSH United States
- Employees
- PCVX N/A
- FRSH N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- FRSH EDP Services
- Sector
- PCVX Health Care
- FRSH Technology
- Exchange
- PCVX Nasdaq
- FRSH Nasdaq
- Market Cap
- PCVX 4.0B
- FRSH 3.7B
- IPO Year
- PCVX 2020
- FRSH 2021
- Fundamental
- Price
- PCVX $45.54
- FRSH $11.65
- Analyst Decision
- PCVX Strong Buy
- FRSH Buy
- Analyst Count
- PCVX 7
- FRSH 16
- Target Price
- PCVX $101.67
- FRSH $19.44
- AVG Volume (30 Days)
- PCVX 1.4M
- FRSH 3.7M
- Earning Date
- PCVX 11-04-2025
- FRSH 11-05-2025
- Dividend Yield
- PCVX N/A
- FRSH N/A
- EPS Growth
- PCVX N/A
- FRSH N/A
- EPS
- PCVX N/A
- FRSH N/A
- Revenue
- PCVX N/A
- FRSH $810,640,000.00
- Revenue This Year
- PCVX N/A
- FRSH $17.01
- Revenue Next Year
- PCVX N/A
- FRSH $13.02
- P/E Ratio
- PCVX N/A
- FRSH N/A
- Revenue Growth
- PCVX N/A
- FRSH 18.18
- 52 Week Low
- PCVX $27.66
- FRSH $10.51
- 52 Week High
- PCVX $107.22
- FRSH $19.77
- Technical
- Relative Strength Index (RSI)
- PCVX 62.28
- FRSH 55.42
- Support Level
- PCVX $40.14
- FRSH $10.52
- Resistance Level
- PCVX $45.90
- FRSH $11.31
- Average True Range (ATR)
- PCVX 2.13
- FRSH 0.35
- MACD
- PCVX -0.27
- FRSH 0.09
- Stochastic Oscillator
- PCVX 92.28
- FRSH 97.81
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.